A Multicenter, Prospective, Clinical Trial Evaluating a Single Layer Amniotic Membrane and Standard of Care Versus Matched Controls in the Management of Nonhealing Pressure Ulcers

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 11, 2025

Primary Completion Date

August 31, 2027

Study Completion Date

August 31, 2027

Conditions
Pressure UlcerUlcer, PressurePressure WoundPressure Area
Interventions
OTHER

Standard of Care

Beginning at the screening visit, participants will receive weekly treatment with standard of care (cleaning, debridement, ulcer moisture balance, and offloading) until ulcer closure, or a maximum of 20 weeks, whichever occurs first.

OTHER

XPURT + SOC

Participants will receive weekly applications of XPURT and Standard of Care until ulcer closure, or a maximum of 20 weeks, whichever occurs first.

Trial Locations (1)

15146

RECRUITING

Serena Group- Monroeville, Monroeville

Sponsors
All Listed Sponsors
collaborator

SerenaGroup, Inc.

NETWORK

lead

Applied Biologics, LLC

INDUSTRY

NCT07126886 - A Multicenter, Prospective, Clinical Trial Evaluating a Single Layer Amniotic Membrane and Standard of Care Versus Matched Controls in the Management of Nonhealing Pressure Ulcers | Biotech Hunter | Biotech Hunter